Life Sciences Investment Forum 2026

Leads regulatory and transactional matters that shape the health and life sciences landscape

Represents private capital investors across buy-side and sell-side dealmaking in the sector

Helps clients structure innovative strategies with business-focused guidance across borders, and across health and life sciences subsectors

Mergers, stock and asset deals, and leveraged buyouts

Venture capital investments and growth financings

Joint ventures, restructurings, and recapitalizations

Private equity and venture-backed transactions

Represents private equity firms, multinational public companies, private companies, and founders in domestic and cross-border M&A, joint ventures, and strategic transactions

Advises buyers and sellers in acquisitions, divestitures, and complex multijurisdictional carve-out transactions in regulated industries

Counsels clients in the life sciences sector, including pharmaceuticals, diagnostics, and medical devices

Provides ongoing counsel to portfolio companies on a wide range of corporate and transactional matters